X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4328) 4328
Publication (431) 431
Book Review (170) 170
Conference Proceeding (11) 11
Book Chapter (6) 6
Dissertation (6) 6
Magazine Article (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4200) 4200
polyglycolic acid - chemistry (2579) 2579
animals (2519) 2519
lactic acid - chemistry (2501) 2501
pharmacology & pharmacy (1986) 1986
humans (1809) 1809
microspheres (1483) 1483
nanoparticles (1457) 1457
particle size (1174) 1174
drug delivery systems (1121) 1121
mice (1058) 1058
male (1035) 1035
nanoparticles - chemistry (939) 939
polyglycolic acid (910) 910
plga (879) 879
female (868) 868
rats (809) 809
chemistry, multidisciplinary (780) 780
polymers (773) 773
poly (750) 750
lactic acid (739) 739
drug carriers - chemistry (729) 729
materials science, biomaterials (722) 722
polymers - chemistry (688) 688
in-vitro (685) 685
drug-delivery (679) 679
analysis (637) 637
drugs (632) 632
engineering, biomedical (608) 608
delivery (601) 601
microparticles (538) 538
release (525) 525
microscopy, electron, scanning (520) 520
vehicles (503) 503
cell line, tumor (476) 476
polyglycolic acid - administration & dosage (461) 461
cancer (441) 441
drug carriers (441) 441
lactic acid - administration & dosage (438) 438
delayed-action preparations (421) 421
polylactic acid-polyglycolic acid copolymer (391) 391
pharmacy (375) 375
rats, sprague-dawley (369) 369
drug delivery (368) 368
solubility (366) 366
surface properties (365) 365
cell survival - drug effects (356) 356
drug compounding (339) 339
tissue engineering (333) 333
cells, cultured (330) 330
in-vivo (329) 329
nanoscience & nanotechnology (324) 324
cells (317) 317
biocompatible materials - chemistry (315) 315
surgery (313) 313
polyglycolic acid - therapeutic use (309) 309
mice, inbred balb c (304) 304
controlled release (301) 301
article (296) 296
plga nanoparticles (293) 293
chemistry, pharmaceutical (291) 291
biomedical engineering (288) 288
degradation (288) 288
nanoparticles - administration & dosage (286) 286
drug delivery systems - methods (282) 282
kinetics (281) 281
polyethylene glycols - chemistry (281) 281
rabbits (280) 280
dentistry (279) 279
controlled-release (276) 276
encapsulation (274) 274
proteins (273) 273
time factors (268) 268
cell line (265) 265
nanotechnology (262) 262
pharmacology/toxicology (261) 261
biochemistry, general (260) 260
biomedicine (260) 260
polylactide-co-glycolide (257) 257
biocompatibility (249) 249
polyglycolic acid - pharmacology (247) 247
medicine, research & experimental (242) 242
medicine (240) 240
therapy (240) 240
plga microspheres (239) 239
delayed-action preparations - chemistry (230) 230
chemotherapy (227) 227
drug liberation (222) 222
formulation (222) 222
lactic acid - pharmacology (221) 221
biotechnology & applied microbiology (220) 220
drug stability (220) 220
technology, industry, and agriculture (218) 218
health aspects (215) 215
protein (215) 215
disease models, animal (213) 213
molecular weight (213) 213
biocompatible materials (212) 212
absorbable implants (211) 211
biomedical materials (210) 210
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4296) 4296
Chinese (15) 15
Japanese (6) 6
French (5) 5
Spanish (4) 4
Portuguese (2) 2
Russian (2) 2
German (1) 1
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Controlled Release, ISSN 0168-3659, 08/2017, Volume 259, pp. 76 - 82
PLGA nanotherapeutics though representing a most promising platform for targeted cancer therapy are confronted with low stability and insufficient tumor cell... 
Coating | PLGA nanoparticles | Nanomedicine | Lung cancer | Docetaxel | DOXORUBICIN | POLYMERIC MICELLES | CHEMISTRY, MULTIDISCIPLINARY | CELLULAR UPTAKE | VITAMIN-E TPGS | BREAST-CANCER | THERAPY | IN-VIVO | PHARMACOLOGY & PHARMACY | CLINICAL TRANSLATION | ANTICANCER DRUG-DELIVERY | PROTEIN DELIVERY | Hyaluronic Acid - therapeutic use | Lung Neoplasms - drug therapy | Drug Carriers - therapeutic use | Nanoparticles - chemistry | Humans | Lung Neoplasms - metabolism | Drug Carriers - administration & dosage | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Polyglycolic Acid - therapeutic use | Drug Carriers - chemistry | Lactic Acid - pharmacokinetics | Taxoids - therapeutic use | Nanoparticles - therapeutic use | Antineoplastic Agents - pharmacokinetics | Lactic Acid - administration & dosage | Polyglycolic Acid - administration & dosage | Taxoids - chemistry | A549 Cells | Cell Survival - drug effects | Hyaluronic Acid - administration & dosage | Lactic Acid - chemistry | Hyaluronic Acid - chemistry | Antineoplastic Agents - chemistry | Hyaluronic Acid - pharmacokinetics | Taxoids - pharmacokinetics | Taxoids - administration & dosage | Animals | Polyglycolic Acid - pharmacokinetics | Tumor Burden - drug effects | Mice, Nude | Polyglycolic Acid - chemistry | Cell Line, Tumor | Drug Carriers - pharmacokinetics | Nanoparticles - administration & dosage | Lactic Acid - therapeutic use | Antimitotic agents | Chemotherapy | Antineoplastic agents | Hyaluronic acid | Cancer | Index Medicus
Journal Article
Biomaterials, ISSN 0142-9612, 2013, Volume 35, Issue 6, pp. 1932 - 1943
Journal Article
Biomaterials, ISSN 0142-9612, 2012, Volume 33, Issue 24, pp. 5854 - 5864
Journal Article
Journal Article
Biomaterials, ISSN 0142-9612, 2010, Volume 31, Issue 35, pp. 9293 - 9300
Abstract Healing of contaminated/infected bone defects is a significant clinical challenge. Prevalence of multi-antibiotic resistant organisms has renewed... 
Advanced Basic Science | Dentistry | Antimicrobial | Bone repair | Nanosilver particle | Bone morphogenetic protein 2 (BMP-2) | MATERIALS SCIENCE, BIOMATERIALS | CEMENT | ENGINEERING, BIOMEDICAL | REGENERATION | SILVER NANOPARTICLES | ANTIBACTERIAL PROPERTIES | IN-VITRO | RESISTANCE | STAPHYLOCOCCUS-AUREUS | EXTRACELLULAR-MATRIX | HIP ARTHROPLASTIES | CHRONIC OSTEOMYELITIS | Immunohistochemistry | Nanocomposites - therapeutic use | Nanocomposites - adverse effects | Nanocomposites - chemistry | Polyglycolic Acid - adverse effects | Bone Morphogenetic Protein 2 - chemistry | Male | Polyglycolic Acid - therapeutic use | X-Ray Microtomography | Bone Morphogenetic Protein 2 - adverse effects | Microbial Sensitivity Tests | Silver - therapeutic use | Bone Morphogenetic Protein 2 - therapeutic use | Anti-Infective Agents - chemistry | Nanocomposites - ultrastructure | Wound Healing - drug effects | Bone Regeneration - drug effects | Cell Line | Microscopy, Electron, Scanning | Lactic Acid - chemistry | Prostheses and Implants - adverse effects | Silver - chemistry | Anti-Infective Agents - therapeutic use | Rats | Rats, Sprague-Dawley | Animals | Polyglycolic Acid - chemistry | Lactic Acid - adverse effects | Prostheses and Implants - ultrastructure | Cell Proliferation - drug effects | Mice | Lactic Acid - therapeutic use | Nanotechnology | Medical colleges | Biological products | Phosphatases | Developmental biology | Bone morphogenetic proteins | Drug resistance | Antibacterial agents | Non-governmental organizations | Index Medicus
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 06/2016, Volume 232, pp. 93 - 102
Intimal hyperplasia (IH) is the major cause of grafted vessel occlusion and occurs frequently after bypass intervention. No pharmaceutical formulation is... 
Perivascular administration | Atorvastatin | Microparticle | Hyaluronic acid hydrogel | Intimal hyperplasia | DRUG-DELIVERY | CASCADE RANDOMIZED-TRIAL | NEOINTIMAL HYPERPLASIA | CHEMISTRY, MULTIDISCIPLINARY | PORCINE MODEL | VENOUS BYPASS | MOUSE CAROTID-ARTERY | STATIN THERAPY | PHARMACOLOGY & PHARMACY | SMOOTH-MUSCLE-CELLS | VEIN GRAFT FAILURE | MOLECULAR-MECHANISMS | Hyaluronic Acid - therapeutic use | Atorvastatin Calcium - administration & dosage | Humans | Hydrogels - pharmacokinetics | Male | Polyglycolic Acid - therapeutic use | Delayed-Action Preparations - administration & dosage | Drug Delivery Systems | Saphenous Vein - metabolism | Tissue Distribution | Lactic Acid - pharmacokinetics | Ligation | Hydrogels - administration & dosage | Delayed-Action Preparations - pharmacokinetics | Hyperplasia - drug therapy | Lactic Acid - administration & dosage | Atorvastatin Calcium - therapeutic use | Polyglycolic Acid - administration & dosage | Atorvastatin Calcium - pharmacokinetics | Hyaluronic Acid - administration & dosage | Mice, Inbred C57BL | Hyaluronic Acid - pharmacokinetics | Animals | Tunica Intima - pathology | Polyglycolic Acid - pharmacokinetics | Delayed-Action Preparations - therapeutic use | Drug Liberation | Carotid Arteries - surgery | Carotid Arteries - pathology | In Vitro Techniques | Lactic Acid - therapeutic use | Hydrogels - therapeutic use | Coronary artery bypass | Hyperplasia | Hyaluronic acid | Product introduction | All terrain vehicles | Medicine, Preventive | Antilipemic agents | Preventive health services | Index Medicus
Journal Article
Biomaterials, ISSN 0142-9612, 2013, Volume 35, Issue 3, pp. 1089 - 1095
Journal Article
Journal Article